On 30 November 2022, the European Commission presented a new EU Global Health Strategy.
The EU Global Health Strategy, aims to establish the EU as a major geopolitical player in healthcare and has been shaped by the perceived shortcomings during the COVID-19 outbreak. The Commission has stated health is now a “geopolitical issue”.
The strategy aims at improving global health security and ensuring better health for citizens, by addressing a range of communicable diseases, such as AIDS, tuberculosis, malaria, and neglected tropical diseases.
Of particular relevance for the in silico medicine community is the fact that the strategy recognizes the need for maximising new opportunities for health offered by powerful enablers, like research and digitalisation, including the use of artificial intelligence.
The new EU Global Health Strategy offers a framework for EU health policies leading up to 2030. In concrete terms, the European Commission put forward three key priorities, namely:
To achieve these three priorities, the Commission proposes several lines of actions, among which :
Lastly, to achieve the objectives of the Strategy, the EU executive calls for new European governance to provide leadership, mobilising all internal and external policies for global health, using Team Europe’s “single, powerful” voice, strengthening coordination with Member States by linking actions and funds to health priorities and monitoring the implementation of the Strategy. Support from the EU4Health programme is envisaged for this project, with the indicative timeline expected for the second half of 2023.